Cite
Oosterhoff D, Lougheed S, van de Ven R, et al. Tumor-mediated inhibition of human dendritic cell differentiation and function is consistently counteracted by combined p38 MAPK and STAT3 inhibition. Oncoimmunology. 2012;1(5):649-658doi: 10.4161/onci.20365.
Oosterhoff, D., Lougheed, S., van de Ven, R., Lindenberg, J., van Cruijsen, H., Hiddingh, L., Kroon, J., van den Eertwegh, A. J., Hangalapura, B., Scheper, R. J., & de Gruijl, T. D. (2012). Tumor-mediated inhibition of human dendritic cell differentiation and function is consistently counteracted by combined p38 MAPK and STAT3 inhibition. Oncoimmunology, 1(5), 649-658. https://doi.org/10.4161/onci.20365
Oosterhoff, Dinja, et al. "Tumor-mediated inhibition of human dendritic cell differentiation and function is consistently counteracted by combined p38 MAPK and STAT3 inhibition." Oncoimmunology vol. 1,5 (2012): 649-658. doi: https://doi.org/10.4161/onci.20365
Oosterhoff D, Lougheed S, van de Ven R, Lindenberg J, van Cruijsen H, Hiddingh L, Kroon J, van den Eertwegh AJ, Hangalapura B, Scheper RJ, de Gruijl TD. Tumor-mediated inhibition of human dendritic cell differentiation and function is consistently counteracted by combined p38 MAPK and STAT3 inhibition. Oncoimmunology. 2012 Aug 01;1(5):649-658. doi: 10.4161/onci.20365. PMID: 22934257; PMCID: PMC3429569.
Copy
Download .nbib